investordatabase.org

OMX Ventures, LLC

omx.vc Direct investor

OMX Ventures is a venture capital firm that invests in biotechnology companies, focusing on therapeutics, bio-tools, diagnostics, and synthetic biology. It operates in the US and Europe.

OMX Ventures, LLC is a venture capital firm headquartered in United States. It invests directly in companies, from seed to Series B, in biotech, therapeutics, BioTools & Diagnostics and synthetic Biology.

“Using a technology-first approach, OMX takes groundbreaking discoveries and grows them into scalable biotech companies on both sides of the Atlantic.”

— OMX Ventures, LLC, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series B
Headquarters
United States
Invests in
US, Europe
Sectors
Biotech, Therapeutics, BioTools & Diagnostics, Synthetic Biology

Team, as OMX Ventures, LLC publishes it

  • Dan Fero Managing Director
  • Craig Asher Managing Director
  • Nick Haft Managing Director
  • Swetha Murali Vice President
  • Natasha Azar Vice President Investor Relations
  • Tim Richardson Venture Partner
  • John Nawrocki Chief Financial Officer
  • Paul Conley Venture Partner
  • Fred Sweeney Venture Partner

Names and roles exactly as listed on omx.vc. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 38 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

and 28 more — the graph.

Where this comes from

Every fact above was read from a page OMX Ventures, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3408 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under